Andrew Redfern
Andrew Redfern
University of Western Australia
Verified email at health.wa.gov.au
Title
Cited by
Cited by
Year
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
BIG 1-98 Collaborative Group
New England Journal of Medicine 361 (8), 766-776, 2009
5492009
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical …
MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ...
The lancet oncology 12 (12), 1101-1108, 2011
3612011
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International …
G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ...
Journal of clinical oncology 26 (34), 5569, 2008
3402008
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
M Rabaglio, Z Sun, KN Price, M Castiglione-Gertsch, H Hawle, ...
Annals of oncology 20 (9), 1489-1498, 2009
1452009
SLIRP, a small SRA binding protein, is a nuclear receptor corepressor
EC Hatchell, SM Colley, DJ Beveridge, MR Epis, LM Stuart, KM Giles, ...
Molecular cell 22 (5), 657-668, 2006
1362006
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib
KM Giles, FC Kalinowski, PA Candy, MR Epis, PM Zhang, AD Redfern, ...
Molecular cancer therapeutics 12 (11), 2541-2558, 2013
1182013
RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators
AD Redfern, SM Colley, DJ Beveridge, N Ikeda, MR Epis, X Li, CE Foulds, ...
Proceedings of the National Academy of Sciences 110 (16), 6536-6541, 2013
1052013
Controversies around epithelial–mesenchymal plasticity in cancer metastasis
ED Williams, D Gao, A Redfern, EW Thompson
Nature reviews Cancer, 1-17, 2019
592019
Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial–mesenchymal plasticity
LM McInnes, N Jacobson, A Redfern, A Dowling, EW Thompson, ...
Frontiers in oncology 5, 42, 2015
582015
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
M Colleoni, W Luo, P Karlsson, J Chirgwin, S Aebi, G Jerusalem, P Neven, ...
The lancet oncology 19 (1), 127-138, 2018
532018
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
PA Candy, MR Phillips, AD Redfern, SM Colley, JA Davidson, LM Stuart, ...
British journal of cancer 109 (4), 1023-1030, 2013
452013
Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/HER2-negative breast cancer—the Evaluating Treatment with …
L Gianni, M Mansutti, A Anton, L Calvo, G Bisagni, B Bermejo, ...
JAMA oncology 4 (3), 302-308, 2018
372018
Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines
J Cursons, KJ Leuchowius, M Waltham, E Tomaskovic-Crook, M Foroutan, ...
Cell Communication and Signaling 13 (1), 26, 2015
372015
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine …
A Giobbie-Hurder, KN Price, RD Gelber
Clinical Trials 6 (3), 272-287, 2009
332009
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial
N Wressnigg, MVW van der Velden, D Portsmouth, W Draxler, ...
Clinical and Vaccine Immunology 22 (3), 267-273, 2015
282015
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies
MS Shawky, H Martin, HJ Hugo, T Lloyd, KL Britt, A Redfern, ...
Oncotarget 8 (3), 5578, 2017
262017
ETNA (Evaluating Treatment with Neoadjuvant Abraxane) randomized phase III study comparing neoadjuvant nab-paclitaxel (nab-P) versus paclitaxel (P) both followed by …
L Gianni, M Mansutti, A Anton, L Calvo, G Bisagni, B Bermejo, ...
Journal of Clinical Oncology 34 (15_suppl), 502-502, 2016
252016
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
AD Redfern, LJ Spalding, EW Thompson
Clinical & experimental metastasis 35 (4), 285-308, 2018
192018
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
European Journal of Cancer 82, 237-246, 2017
192017
Cancer services in W estern A ustralia: A comparison of regional outcomes with metropolitan P erth
HL Martin, K Ohara, W Chin, A Davidson, E Bayliss, A Redfern, ...
Australian Journal of Rural Health 23 (5), 302-308, 2015
132015
The system can't perform the operation now. Try again later.
Articles 1–20